Harm reduction

Sessions

PDF version
Wednesday, 23 October

10:00

e-poster session day 1

to
Digital kiosks
e-poster session

11:50

Sex, gender and diversity in drugs

to
Auditorium IV
Oral presentation session

Advancing addiction research: global perspectives and collaborative initiatives

to
Auditorium VI
Oral presentation session

Lives at risk: mental health and substance use

to
Auditorium VII
Oral presentation session

Prevalence of opioids and related harms

to
Auditorium VIII
Oral presentation session

Mechanisms and outcomes in substance use prevention among youth

to
Room 5A
Oral presentation session

Building addiction workforce capacity

to
Room 5C
Oral presentation session

Evaluation of drug consumption rooms: guidance step by step

to
Room 1.15
Workshop

14:20

Enhancing access to harm reduction services in community and prisons: experiences of translating policy into practice and scaling interventions

to
Auditorium I
Major session

Drug policy and the criminal legal system

to
Auditorium VI
Oral presentation session

Challenge of measuring use and impact of cannabinoids

to
Room 1.07
Oral presentation session

Methods and measurement

to
Room 1.08
Short communication session

The peer model: the critical role of ethics in efficacy

to
Room 1.15
Workshop

16:00

Challenges in community-based prevention

to
Auditorium I
Major session

The recovery journey

to
Auditorium III
Oral presentation session

Infectious diseases in people who inject drugs

to
Auditorium IV
Oral presentation session

Measuring drug market phenomenon

to
Auditorium VI
Oral presentation session

Surveillance of drug-related morbidity and mortality

to
Room 5A
Oral presentation session

Inequalities and needs of migrant groups

to
Room 5C
Oral presentation session

Quality in addictions work systems

to
Room 1.06
Oral presentation session

Problematic gambling and gaming

to
Room 1.07
Short communication session

Conceptualising health and harms

to
Room 1.08
Short communication session

17:50

Drug use trends

to
Auditorium IV
Oral presentation session

Psychedelics 1

to
Auditorium VIII
Oral presentation session

Novel and contextual approaches in prevention

to
Room 5A
Oral presentation session

Opioid treatment 1

to
Room 5B
Oral presentation session

Motivations for use

to
Room 5C
Oral presentation session

Hepatitis C, HIV, and other drug related harms

to
Room 1.05
Short communication session

Opioids: trends, use and treatments

to
Room 1.06
Short communication session

19:30

Why are we not doing better at reducing drug-related deaths?

to
Auditorium I
Big debate
Thursday, 24 October

11:50

Opioid Agonist Treatment: novel formulations and challenges

to
Auditorium IV
Oral presentation session

Evidence informed drug and alcohol policy

to
Auditorium VI
Oral presentation session

Emerging drug harms, DCRs and other responses

to
Auditorium VII
Short communication session

Innovative methods for understanding drug markets and policy

to
Room 5A
Oral presentation session

Workers reaching marginalised groups

to
Room 5C
Oral presentation session

Contemporary issues

to
Room 1.08
Oral presentation session

Back-casting exercise on peer-support workforce development

to
Room 1.15
Workshop

14:20

Understanding drug-related deaths

to
Auditorium IV
Oral presentation session

Conceptual frameworks for studying drug policy

to
Auditorium VI
Oral presentation session

Young people, mental health and substance use

to
Auditorium VII
Oral presentation session

Co-creating robust systems with workers

to
Room 5C
Oral presentation session

Understanding harm reduction: economic, social, and health perspectives

to
Room 1.05
Short communication session

Women's realities of drug use

to
Room 1.08
Oral presentation session

16:00

Hepatitis C testing and treatment

to
Auditorium IV
Oral presentation session

From genes to brains

to
Room 1.06
Short communication session

City insights: creating a collaborative network for city-level monitoring of drug trends and harm reduction

to
Room 1.07
Workshop

17:50

Mixed methods for understanding drug use

to
Auditorium III
Oral presentation session

Substance use and mental health in treatment settings

to
Auditorium VII
Oral presentation session

Misuse of medicines

to
Auditorium VIII
Oral presentation session

From old to new: changes in drug use

to
Room 5C
Oral presentation session
Friday, 25 October

11:50

Intentional and non-intentional drug-related deaths

to
Auditorium IV
Oral presentation session

Psychedelics 2

to
Auditorium VI
Oral presentation session

Drugs checking services

to
Room 5A
Oral presentation session

Online monitoring

to
Room 5B
Oral presentation session

Emerging challenges in drug markets: monitoring, measurement & impacts

to
Room 1.05
Short communication session

Gaming and health

to
Room 1.06
Short communication session

Support for the addiction workforce

to
Room 1.07
Oral presentation session

14:20

Young people and drugs

to
Auditorium III
Oral presentation session

Overdose prevention

to
Auditorium IV
Oral presentation session

Holistic care for mental well-being

to
Room 1.05
Short communication session

Presentations

Wed 23 Oct

10:00

e-poster

"How generational transmissions can shape life?" Evaluation of a genogram group therapy for people with ACoA syndrome

10:00 to 19:20
Digital kiosks
Katarzyna Iwanicka

e-poster

"Make the difference" - Qualifying professionals working with families with addiction issues

10:00 to 19:20
Digital kiosks
Rebekka Kleinat

e-poster

"Pictures (and Drugs) at an exibition"

10:00 to 19:20
Digital kiosks
Patrizio Lamonaca

e-poster

"Supersavers" manages large proportion of opioid overdoses – 5-year follow-up of a regional naloxone program, Sweden

10:00 to 19:20
Digital kiosks
Katja Troberg

e-poster

30 years of New Psychoactive Substances (NPS) in Europe. A first integrated public health assessment.

10:00 to 19:20
Digital kiosks
Julian Vicente

e-poster

A business of supplying harm reduction : a necessary evil?

10:00 to 19:20
Digital kiosks
François Destombe

e-poster

A digital approach to peer led recovery and social connection to address substance use/and or mental health challenges

10:00 to 19:20
Digital kiosks
Susan Barnes

e-poster

A feasibility and tolerability study of home-use tDCS in patients with substance use disorders (SUD)

10:00 to 19:20
Digital kiosks
Laia Miquel

e-poster

A Look at Non-Compliance: Examining Alcohol Industry Marketing Practices in Portugal

10:00 to 19:20
Digital kiosks
Hilson Cunha Filho

e-poster

A narrative review of nurse-led addiction models of care; informing the foundations for international nursing.

10:00 to 19:20
Digital kiosks
Sadie Lavelle Cafferkey

e-poster

A National Survey of Alcohol Care Teams (ACTs) in England: Characteristics of Patients and Components of Care

10:00 to 19:20
Digital kiosks
Philippa Case

e-poster

A Prospective Study: Patterns and Trends in Opioid Use and Treatment with Focus on Older Populations

10:00 to 19:20
Digital kiosks
Jo-Hanna Ivers

e-poster

A systematic review of second-hand smoking mass media campaigns (2002-2022)

10:00 to 19:20
Digital kiosks
Carmen Lim

e-poster

Activities and Experiences of Czech Adolescents in Cyberspace

10:00 to 19:20
Digital kiosks
Martin Dolejš

e-poster

Acute and Chronic Effects of Cannabis on the Neural Correlates of Working Memory in Adolescents versus Adults

10:00 to 19:20
Digital kiosks
Sorcha Hamilton

e-poster

Addiction, a volitional disorder.

10:00 to 19:20
Digital kiosks
Nicolas Figueired

e-poster

Addiction-related dreams: Interpretative Phenomenological Analysis of content and recovery from addiction

10:00 to 19:20
Digital kiosks
Shawn Rutledge

e-poster

Addictive Behaviours Workforce development: from global to European higher education programs

10:00 to 19:20
Digital kiosks
Olatz López Fernández

e-poster

ADDIRIS - Addiction and Harm Reduction: a global French-speaking network for online learning

10:00 to 19:20
Digital kiosks
Romain Bach

e-poster

Adherence to Opioid Use Disorder treatment with an extended-release weekly and monthly injectable buprenorphine

10:00 to 19:20
Digital kiosks
Michael Frost

e-poster

Advancing Addiction Interventions: Porto's Comprehensive Approach in the Municipal Health Plan

10:00 to 19:20
Digital kiosks
Paula Pinto Oliveira

e-poster

Adverse childhood experiences, adult attachment and parenting styles in a population with addictive behaviors

10:00 to 19:20
Digital kiosks
Teodomiro Pires

e-poster

Ageing in the context of the Opioid Maintenance Treatment in Portugal: Impact of public health policies on ageing users

10:00 to 19:20
Digital kiosks
Lara Queiroz Sampaio

e-poster

Alcohol use across trials of psychological interventions for bipolar: A systematic review and meta-analysis

10:00 to 19:20
Digital kiosks
Lauren Halsall

e-poster

Alcohol, Driving and Crime - Health Care and Justice: An Outreach Intervention

10:00 to 19:20
Digital kiosks
Celestino Cunha

e-poster

Alcohol, transitions and communities of belonging within marginalised groups – towards a model of understanding.

10:00 to 19:20
Digital kiosks
Peter Nelson

e-poster

An audit of patient’s Health / Social Care needs referred to a Dual Diagnosis Social Care pathway in Ireland

10:00 to 19:20
Digital kiosks
Aidan Cooney

e-poster

An evaluation of “harm reduction” outreach service evaluative research in Macau

10:00 to 19:20
Digital kiosks
Augusto Nogueira

e-poster

Anabolic steroid use and use of other image- and performance-enhancing drugs on the rise – A new substance use disorder

10:00 to 19:20
Digital kiosks
Raphael Magnolini

e-poster

Analysis of the satisfaction survey results of users of the Mobile Drug Consumption Room Program in Lisbon

10:00 to 19:20
Digital kiosks
Adriana Almeida

e-poster

Anxiety, Depression, Stress, and Self-Harm in relation to Gaming Disorder: A Longitudinal Study of Czech Adolescents

10:00 to 19:20
Digital kiosks
Jaroslava Suchá

e-poster

Applied health research in alcohol-related liver disease: a rapid qualitative inquiry with healthcare providers

10:00 to 19:20
Digital kiosks
Sofia Hemrage

e-poster

Applying foresight research for drug policy: Lessons from the DRUG-PREP project

10:00 to 19:20
Digital kiosks
Bert Hauspie

e-poster

Are Patients with Schizophrenia Reliably Reporting their Cannabis Use? An African Cross-sectional Study

10:00 to 19:20
Digital kiosks
Said Boujraf

e-poster

Assessing Food Security and Hunger in Heroin-Assisted Treatment (HAT) Participants: Insights from Norway's HAT Project

10:00 to 19:20
Digital kiosks
Omid Dadras

e-poster

Assessing hindering and facilitating factors of help-seeking behaviour in cannabis use: descriptive qualitative study

10:00 to 19:20
Digital kiosks
Laura Väätäinen

e-poster

Assessing progress towards viral hepatitis B and C elimination in prison settings in the European region

10:00 to 19:20
Digital kiosks
Riccardo Pisetta

e-poster

Assessing the prevalence of problem gambling among the Slovenian population

10:00 to 19:20
Digital kiosks
Špela Selak

e-poster

Assessing Therapeutic Alliance: A Pilot Study Measuring Therapeutic Alliance and It's Impact on Patient Outcomes

10:00 to 19:20
Digital kiosks
Siobhan Morse

e-poster

Association between slot machine gambling and debt recovery process-Finnish population-based study with register linkage

10:00 to 19:20
Digital kiosks
Tiina Latvala

e-poster

Balancing between care and control - staff perception on the introduction of new medication for opioid agonist treatment

10:00 to 19:20
Digital kiosks
Andrea Johansson Capusan

e-poster

Barriers to Substance Use Treatment as Perceived by Professionals and Arabic Refugees in Germany

10:00 to 19:20
Digital kiosks
Ebtesam Saleh

e-poster

Benefits of a Yoga intervention in portuguese female inmates: preliminary results

10:00 to 19:20
Digital kiosks
Andreia Nisa

e-poster

Building Capacity for Social Return on Investment Analysis of Supervised Consumption Services in Saskatoon SK, Canada

10:00 to 19:20
Digital kiosks
Barbara Fornssler

e-poster

Buprenorphine prescription patterns at a tertiary care hospital in northern India: A retrospective chart review

10:00 to 19:20
Digital kiosks
Abhishek Gupta

e-poster

Burden of disease due to drug use disorders in the European Union: analysis of 1990-2019 trends and patterns

10:00 to 19:20
Digital kiosks
Vera Pinheiro

e-poster

Burnout and Engagement in Addictive Behaviors and Dependencies HCWs at Portuguese North Region: an epidemiological study

10:00 to 19:20
Digital kiosks
Cátia Coutinho

e-poster

Can we prevent the misuse of prescription stimulants? : a case report

10:00 to 19:20
Digital kiosks
Ivana Todorić Laidlaw

e-poster

Cannabis use and its link to psychopathological and functional outcomes: Insights from self-reports and hair data

10:00 to 19:20
Digital kiosks
Lydia Johnson-Ferguson

e-poster

Cannabis use and severity of cannabis dependence among Georgian small-scale cannabis growers in 2021

10:00 to 19:20
Digital kiosks
Tamari Mgebrishvili

e-poster

Cannabis use and withdrawal and escalation to psychiatric intensive care

10:00 to 19:20
Digital kiosks
Edward Chesney

e-poster

Caring with Care: VITAE’s integrative and therapeutic model towards socially vulnerable individuals

10:00 to 19:20
Digital kiosks
Brenda Sousa da Silva

e-poster

Case Series: Prospective Study on the Efficacy of Pregabalin in Managing Opioid Withdrawal Syndrome

10:00 to 19:20
Digital kiosks
Sofia Golbreich

e-poster

Catalysts for Change: Youth-Driven Insights in Opioid Harm Reduction

10:00 to 19:20
Digital kiosks
Rebeca Calzada

e-poster

Challenges and needs of Cologne's open drug scene: insights from a quantitative study on Neumarkt square

10:00 to 19:20
Digital kiosks
Daniel Deimel

e-poster

Challenges in the management of skin and soft tissue infections among people who inject drugs in Athens, Greece.

10:00 to 19:20
Digital kiosks
Apostolia Fragkouli

e-poster

Changes in self-reported alcohol use post absolute alcohol sales bans: the case of Botswana during COVID pandemic.

10:00 to 19:20
Digital kiosks
J. Maphisa Maphisa

e-poster

Characterising South Africa’s drug markets with people who sell heroin, methamphetamine and cocaine

10:00 to 19:20
Digital kiosks
MJ Stowe

e-poster

Chemsex: An Umbrella Review

10:00 to 19:20
Digital kiosks
Liam Johnstone

e-poster

Combination non-medical use of gabapentin and medications for opioid use disorder: A qualitative study

10:00 to 19:20
Digital kiosks
Mance Buttram

e-poster

Common mental disorders in prisoners with childhood trauma and substance use; the role of emotion regulation

10:00 to 19:20
Digital kiosks
Faridah Nakoma

e-poster

Community led networking and advocacy for the elimination of discrimination of women who use drugs in Europe

10:00 to 19:20
Digital kiosks
Ligia Parodi

e-poster

Comorbid bloodborne diseases among people with opioid use disorders on medication-assisted treatment in Tanzania.

10:00 to 19:20
Digital kiosks
Dorothy Mushi

e-poster

COMPARED RETENTION RATES BETWEEN PATIENTS TREATED WITH BUVIDAL IN FRANCE vs. SUBLINGUAL BUPRENORPHINE (OPALE-2 STUDY)

10:00 to 19:20
Digital kiosks
Alice Deschenau

e-poster

Comparison of HOMA-IR, Tg/Glucose Index and Tg/HDL-C ratio for predicating MetSy in HCV seronegative heroin dependents

10:00 to 19:20
Digital kiosks
Zanina Perevska

e-poster

Complicated Alcohol Withdrawal Syndrome: retrospective study of an inpatient alcohol treatment unit

10:00 to 19:20
Digital kiosks
Ines Pereira

e-poster

ComunicAr’te - Communicating through Art in Group Therapy on Addictive Behaviors

10:00 to 19:20
Digital kiosks
Carla Matias

e-poster

Conceptual competence in addiction: integrative contributions from philosophical and theoretical work in psychiatry

10:00 to 19:20
Digital kiosks
Carl Erik Fisher

e-poster

Contribution of the workforce to retention of clients in Kombani Medically Assisted Therapy (MAT) in Kwale, Kenya.

10:00 to 19:20
Digital kiosks
Esther Mumo

e-poster

Cortical thickness and brain aging in individuals engaging in unhealthy alcohol use

10:00 to 19:20
Digital kiosks
Marco Hermesdorf

e-poster

COVID-19 and earthquakes-related stress, quality of life, mental health, and internet-based addictive behaviour

10:00 to 19:20
Digital kiosks
Tina Peraica

e-poster

Crack cocaine use, street life and migrant population. An Italian observatory by ItaRdd, Cnca, Forum Droghe.

10:00 to 19:20
Digital kiosks
Luca Censi

e-poster

Critical assessment of the role of compulsory treatment of drug use disorders in Germany

10:00 to 19:20
Digital kiosks
Ingo Ilja Michels

e-poster

DCR in Paris : a constant experiment

10:00 to 19:20
Digital kiosks
Victor Detrez

e-poster

Degree of smartphone addiction in the university environment

10:00 to 19:20
Digital kiosks
Raul Vernet

e-poster

Developing a Toolkit for health care professionals working with Pregnant People who use Drugs in Southern Africa

10:00 to 19:20
Digital kiosks
Julie-Anne Mac Donnell

e-poster

Developing practical tools for identifying and supporting treatment-relevant cognitive dys/functions

10:00 to 19:20
Digital kiosks
Maria Bravo Aguilera

e-poster

Development of complementary information to drug-related deaths statistics in Slovenia

10:00 to 19:20
Digital kiosks
Mateja Jandl

e-poster

Doping Prevention among Recreational Athletes and the Role of the Police

10:00 to 19:20
Digital kiosks
Tobias Elgán

e-poster

Drug checking via Syringe Vending Machines

10:00 to 19:20
Digital kiosks
Mariam Sherozia

e-poster

Drug-Facilitated Sexual Assaults involving GHB and GBL in Europe – recent evidence and a need for better monitoring.

10:00 to 19:20
Digital kiosks
María Flores López

e-poster

Drug-Related Deaths following Bariatric surgery: Case Series Report

10:00 to 19:20
Digital kiosks
Eman Mshari

e-poster

DUDIT-E Brazilian Adaptation and TrIE-AD Application Development: A Intervention Approach for Young Drug Users

10:00 to 19:20
Digital kiosks
Richard Alecsander Reichert

e-poster

Effectiveness of the brief intervention for methamphetamine users in Poland

10:00 to 19:20
Digital kiosks
Magdalena Rowicka

e-poster

Effects of a universal school based alcohol prevention intervention

10:00 to 19:20
Digital kiosks
Bert Hauspie

e-poster

Effects of oxytocin and nicotine addiction on psychosocial stress: an fMRI study

10:00 to 19:20
Digital kiosks
Jiecheng Ren

e-poster

Efficacy of a digital intervention to reduce or stop cannabis use : study protocol for a randomized controlled trial

10:00 to 19:20
Digital kiosks
Emmanuel Lahaie

e-poster

Electroencephalographic indices of stages of reward memory and implications for therapeutic memory reconsolidation

10:00 to 19:20
Digital kiosks
Shelan Ofori

e-poster

Electronic cigarettes use among secondary school students in Slovenia

10:00 to 19:20
Digital kiosks
Helena Koprivnikar

e-poster

Empowering higher education teachers using tripartite drug awareness training model to support youth well-being

10:00 to 19:20
Digital kiosks
Munir Sewani

e-poster

Enhanced Alcohol-Specific Pavlovian-to-Instrumental Transfer in Alcohol Use Disorder

10:00 to 19:20
Digital kiosks
Michael Smolka

e-poster

Enhancing HIV Self-Testing Uptake through Syringe Vending Machines: A Case Study in Tbilisi, Georgia

10:00 to 19:20
Digital kiosks
Irma Kirtadze

e-poster

Enrichment of Prevention Methodologies with Self Help/Mutual aid practices: The case of the Centre of Prevention Greece

10:00 to 19:20
Digital kiosks
Sotiris Lainas

e-poster

Estimation of prevalence (and patterns) of cannabis use from various data sources

10:00 to 19:20
Digital kiosks
Darja Lavtar

e-poster

Ethical considerations of responsible gambling in metaverse

10:00 to 19:20
Digital kiosks
Susanne Uusitalo

e-poster

Evaluation of a UK Bristol capillary blood service for blood-borne virus detection to reach HCV elimination targets

10:00 to 19:20
Digital kiosks
Stephanie Hutchings

e-poster

Evaluation of inpatient conversion from high dose methadone to long-acting injectable buprenorphine (LAIB)

10:00 to 19:20
Digital kiosks
Stuart Fisher

e-poster

Evaluation of participants' experiences enrolled in a community-based mobile withdrawal management service

10:00 to 19:20
Digital kiosks
Andrew Lodge

e-poster

Experiences of female substance users with trauma-sensitive yoga as complementary support in addiction treatment

10:00 to 19:20
Digital kiosks
Julie Schamp

e-poster

Experiences with Xylazine among Residential Treatment Patients

10:00 to 19:20
Digital kiosks
Courtney Nordeck

e-poster

Exploring Cultural Dynamics of Black Asian Ethnic Women in Addiction Recovery

10:00 to 19:20
Digital kiosks
Shinasa Shahid

e-poster

Exploring Diverse Applications of Multicriteria Decision Analysis in Drug Policy: A Comprehensive Overview.

10:00 to 19:20
Digital kiosks
Nicola Worcman

e-poster

Exploring dual diagnosis in opioid agonist treatment: A comparative study between the Czech Republic and Norway

10:00 to 19:20
Digital kiosks
Svetlana Skurtveit

e-poster

Exploring the gendered impact on women of the impact of the changes in commissioning in drug and alcohol services.

10:00 to 19:20
Digital kiosks
Victoria Beere

e-poster

Exploring the role of gender on treatment outcomes in older adults with alcohol use disorder

10:00 to 19:20
Digital kiosks
Jeppe Tryggedsson

e-poster

Features and correlates of Internet Gaming Disorder in women and men who play video games: a cross-national study

10:00 to 19:20
Digital kiosks
Caitlin McClure-Thomas

e-poster

Fentanyl among adolescent in Poland - the scale of the phenomenon and preventive actions

10:00 to 19:20
Digital kiosks
Ewelina Silecka-Marek

e-poster

Forgotten children - losses of children growing up with addicted parents

10:00 to 19:20
Digital kiosks
Szilvia Kassai

e-poster

Framing alcohol policies in non-prohibitionist States: An existentialist dilemma?

10:00 to 19:20
Digital kiosks
Subrata Biswas

e-poster

Frequency of cannabis and amphetamine use past month in patients on opioid maintenance treatment with buprenorphine

10:00 to 19:20
Digital kiosks
Natasha Simonovska

e-poster

From intrusive memory to craving in cocaine use disorder – An ecological momentary assessment study

10:00 to 19:20
Digital kiosks
Amelie Zacher

e-poster

Gender violence experienced by women who use drugs

10:00 to 19:20
Digital kiosks
Ana Isabel Ibar-Fañanás

e-poster

Generative AI to support Harm Reduction

10:00 to 19:20
Digital kiosks
Angus Bancroft

e-poster

Global trends and Challenges of the Drug Phenomenon in Central Asia

10:00 to 19:20
Digital kiosks
Ernest Robello

e-poster

Gratitude amidst unease: Interviews with Swedish forensic psychiatric male patients with substance use disorder

10:00 to 19:20
Digital kiosks
Charlotta Svensson

e-poster

Harm Reduction: A Pathway To Community Health in Nigeria

10:00 to 19:20
Digital kiosks
Fatima Abiola Popoola

e-poster

HCV screening in the treatment centers for people with addictions: lessons learned

10:00 to 19:20
Digital kiosks
Federica Mathis

e-poster

Hepatitis C and pharmaceutical multinationals. An approach to the case of Basque Country (Spain) in 2014/2015

10:00 to 19:20
Digital kiosks
Unai Perez de San Roman Landa

e-poster

High and repeated use of MDPV induce chronic psychosis in patients with no psychiatric history

10:00 to 19:20
Digital kiosks
Andrea Anastasi

e-poster

HIV among people who inject drugs in Stockholm - prevalence, incidence and treatment outcomes

10:00 to 19:20
Digital kiosks
Martin Kåberg

e-poster

Hospitalizations due to the use of psychoactive substances in Portugal: Impact assessment of the 2008 economic crisis

10:00 to 19:20
Digital kiosks
Joana Silva

e-poster

Hybrid skills transfer of the unplugged prevention programme in a French high school abroad (Lisbon, Portugal 2023 2024)

10:00 to 19:20
Digital kiosks
Marion Fal

e-poster

Identification and treatment of alcohol use disorder with the 15-method – implementation in psychiatric care

10:00 to 19:20
Digital kiosks
Jennie Sundbye

e-poster

If you don't know where you're going, why insist on running - A reflection on the lack of data on dropout...

10:00 to 19:20
Digital kiosks
Sofia Freitas

e-poster

Image and performance enhancing drugs among gym and fitness visitors in Slovenia – preliminary results

10:00 to 19:20
Digital kiosks
Julijana Zucchiati Godina

e-poster

Impact of Adherence to the Opioid Substitution Program on Social Determinants of Health in the West Zone of Porto

10:00 to 19:20
Digital kiosks
Isabel Ponte

e-poster

Impact of first cardiovascular event versus consecutive episodes on tobacco and alcohol use: a comprehensive analysis

10:00 to 19:20
Digital kiosks
Maria Teresa Pons

e-poster

Impact of fruit smoothie supplementation on psychological distress in patients undergoing opioid agonist therapy

10:00 to 19:20
Digital kiosks
Elaheh Javadi Arjmand

e-poster

Impact of the Decriminalization on Drug Use Experiences and Related Risks among People Who Use Drugs in British Columbia

10:00 to 19:20
Digital kiosks
Cayley Russell

e-poster

Implementation of a subject on the care of addiction in the Nursing degree: origin of the need and expectations.

10:00 to 19:20
Digital kiosks
Sheimah El Beijjaji Bouzbita

e-poster

Implementation of two transdiagnostic psychological interventions for alcohol use: Study protocol, preliminary results

10:00 to 19:20
Digital kiosks
Alba Abanades

e-poster

Improving the diagnosis and clinical outcomes on drug addict patients through quantitative spectrometer testing.

10:00 to 19:20
Digital kiosks
Teodora Ciolompea

e-poster

In search of protective factors against burnout in Addictive Behaviors and Dependencies HCWs at Portuguese North Region

10:00 to 19:20
Digital kiosks
Rui Tinoco

e-poster

IN VITRO INHIBITORY POTENTIAL OF CLASSIC HALLUCINOGENS LSD, 5-MEO-DMT AND MESCALINE OVER CYTOCHROME P450 ENZYMES

10:00 to 19:20
Digital kiosks
Mariana Carvalho

e-poster

Inpatient ketamine detoxification, characterization of a treatment-seeking population with complex needs

10:00 to 19:20
Digital kiosks
Osunwale Oni

e-poster

Integrating Seven Challenges Mastery Counselling and Trauma Informed Care in adolescent substance use interventions.

10:00 to 19:20
Digital kiosks
Daniel Mercieca

e-poster

Intervention methods for the psychological problems faced by the wives of individuals with substance use disorders.

10:00 to 19:20
Digital kiosks
Ranasinghe Mudiyanselage Sanjeewani Senevirathne

e-poster

Investigating the relationship between defense styles and treatment motivation of Turkish males with alcohol use problem

10:00 to 19:20
Digital kiosks
Fatmatüz Zehra Pehlivan

e-poster

Investigating the Relationship Between Stigma and Relapse in IDUs with HIV/AIDS in Pakistan

10:00 to 19:20
Digital kiosks
Jawwad Muhammad Shujaat

e-poster

Is addiction a brain-disease? An overview of the evidence

10:00 to 19:20
Digital kiosks
Chrysanthi Blithikioti

e-poster

Is Decriminalising drugs enough? Navigating alternatives to prohibitionism

10:00 to 19:20
Digital kiosks
Jorge Quintas

e-poster

Is Integrating Online Stop Smoking Support to Existing Online Talking Therapy Support Feasible?

10:00 to 19:20
Digital kiosks
Pamela Jacobsen

e-poster

Italian teenagers’ perceived exposure to Digital Alcohol Marketing

10:00 to 19:20
Digital kiosks
Franca Beccaria

e-poster

Italian Validation of Assessment of Recovery Capital Scale in Clinical Population with Alcohol and Drugs Use Disorder

10:00 to 19:20
Digital kiosks
Teo Vignoli

e-poster

Leveraging AI to supercharge the training and support of extended workforce in addiction services

10:00 to 19:20
Digital kiosks
Christina Todorova

e-poster

LGBTQIA2S+ perspectives on problem gambling among their peers: Preliminary results of semi-structured interviews

10:00 to 19:20
Digital kiosks
Anne-Marie Auger

e-poster

Life Entrapment or Trampoline? Understanding life experiences of rejected asylum seekers in Copenhagen’s open drug scene

10:00 to 19:20
Digital kiosks
Arash Setoodeh

e-poster

Lived/Living experiences: the potential for integrative collaborations

10:00 to 19:20
Digital kiosks
Mary Beth Zeni

e-poster

Long-term Effects of the STAD-model: A Multi-Component Responsible Beverage Service Intervention

10:00 to 19:20
Digital kiosks
Johanna Gripenberg

e-poster

Long-Term Outcomes of Substance Use Treatment: A 20-Year Follow-Up Study in the Swedish Addiction Treatment System

10:00 to 19:20
Digital kiosks
Tove Sohlberg

e-poster

Love Addiction: Trait Impulsivity, Emotional Dysregulation and Attachment Style

10:00 to 19:20
Digital kiosks
Jessica Dineen

e-poster

Making Hep C treatment more accessible for addictions patients in Belfast

10:00 to 19:20
Digital kiosks
Andrew Teeney

e-poster

Mania a Potu: Review of the literature

10:00 to 19:20
Digital kiosks
Ines Valada

e-poster

Mapping drug users’ spaces of fear in Cologne, Germany

10:00 to 19:20
Digital kiosks
Bo Tackenberg

e-poster

Mapping psychedelic retreats and other practices in the EU

10:00 to 19:20
Digital kiosks
Tereza Černíková

e-poster

Meaning and Self-control in Alcohol Use and Internalizing Symptoms: Causal Insights from (Non)clinical Populations

10:00 to 19:20
Digital kiosks
Marcel Näther

e-poster

Medicinal use of non-prescribed cannabis: motives for use, perceived effectiveness and barriers to treatment (MEDUSA)

10:00 to 19:20
Digital kiosks
Lisa Strada

e-poster

Mortality among long-term prescription opioid users

10:00 to 19:20
Digital kiosks
Gabriela Rolová

e-poster

Mortality Rates and cause-specific mortality in Patients with Substance-Induced Psychosis

10:00 to 19:20
Digital kiosks
Pihla Sassi

e-poster

Navigating cannabis access in zurich: A road safety perspective from early observations of the 'Züri Can' study

10:00 to 19:20
Digital kiosks
Patricia Dürler

e-poster

Negative affectivity, mania, and defense mechanisms in compulsive online buying-shopping disorder

10:00 to 19:20
Digital kiosks
Marina Cosenza

e-poster

Neurocognitive Impulsivity in Opiate Users at Different Lengths of Abstinence

10:00 to 19:20
Digital kiosks
Elena Psederska

e-poster

New criminal legal strategies towards a more effective inmate treatment (The KETHEA PROMITHEAS project)

10:00 to 19:20
Digital kiosks
Apostolos Tsirgoulas

e-poster

Nightlife recreational contexts in Viseu: sexism, sexual violence and potential associations with substance use

10:00 to 19:20
Digital kiosks
Inês Miguel Rodrigues Armelim

e-poster

No alcohol at night – Polish experiences

10:00 to 19:20
Digital kiosks
Marta Zin-Sedek

e-poster

Offspring of individuals with alcohol use disorders and professionals in addiction counseling: A qualitative study

10:00 to 19:20
Digital kiosks
Fran Calvo

e-poster

Oniomania: a case study according to the differential diagnosis

10:00 to 19:20
Digital kiosks
Sofia Nunes

e-poster

Oniomania: what is known today?

10:00 to 19:20
Digital kiosks
Margarida Duarte

e-poster

Online gambling and betting in India and their adverse psychological and social complications: A comprehensive review

10:00 to 19:20
Digital kiosks
Shyam Sundar Kanagarajan

e-poster

Online gambling and Loneliness: A State of Knowledge.

10:00 to 19:20
Digital kiosks
Volanirina Rasolofomamonjy

e-poster

Opiate-Dependent Service Users knowledge and attitudes towards Supervised Injecting Facilities

10:00 to 19:20
Digital kiosks
Annika Gibbons

e-poster

Optimizing Overdose Response in the Emergency Department: New challenges and initiatives in Scotland

10:00 to 19:20
Digital kiosks
Lisa Schölin

e-poster

OUTCAST REGISTRATION: an archive of imprisoned female drug users' biographies

10:00 to 19:20
Digital kiosks
Ulrike Möntmann

e-poster

Packaging of disposable vaping products and e-liquids in England, Canada, and the United States: a content analysis

10:00 to 19:20
Digital kiosks
Matilda Nottage

e-poster

People with mental disorders resulting in addiction to alcohol in Poland - legal aspects of medical, social assistance.

10:00 to 19:20
Digital kiosks
Joanna Rajewska de Mezer

e-poster

Personality traits and recovery

10:00 to 19:20
Digital kiosks
Elise Constance Fodstad

e-poster

Pilot implementation of a drug overdose reporting tool among Texas harm reduction organizations: A mixed methods study

10:00 to 19:20
Digital kiosks
Jake Samora

e-poster

Piloting a strategy to prevent and manage alcohol-related problems in underage population at risk in health services

10:00 to 19:20
Digital kiosks
Carla Filipa Bruguera

e-poster

Portuguese gym-goers versus Performance-enhancing Substances: What do we know?

10:00 to 19:20
Digital kiosks
Ana Sofia Tavares

e-poster

Post-prison support for First Nations men in Australia and Canada

10:00 to 19:20
Digital kiosks
Michael Doyle

e-poster

Prevalence of BBD among PWID in treatment settings in Palestine between 2019-2023

10:00 to 19:20
Digital kiosks
Abeer Habash

e-poster

Prevalence of substance use in Austrian prison systems

10:00 to 19:20
Digital kiosks
Andrea Gamper

e-poster

Prevention Matters: Towards a National Model of Prevention (within the National Programme on Illicit Drugs 2023 - 2030)

10:00 to 19:20
Digital kiosks
Mateja Markl

e-poster

Prevention of FASD in Luxembourg – a status report

10:00 to 19:20
Digital kiosks
Jonathan Uselding

e-poster

Problematic Mobile Phone Use Related Changes in Topological Organization of Functional Brain Networks

10:00 to 19:20
Digital kiosks
Lichang Yao

e-poster

Process indicators and outcomes of patients with SUD and Emotional Disorders: Comparison of pre-post COVID-19 pandemic

10:00 to 19:20
Digital kiosks
Oscar M. Lozano

e-poster

Professional satisfaction and discontent: perspectives of health professionals on Addictive Behaviors and Dependencies

10:00 to 19:20
Digital kiosks
Rita Valinho

e-poster

Program evaluation of a team-based approach addressing mental health and addictions in a Canadian urban centre

10:00 to 19:20
Digital kiosks
Andrew Lodge

e-poster

Providing psychiatric services for hepatitis C virus patients with substance use disorders

10:00 to 19:20
Digital kiosks
Anna Gorodetsky

e-poster

Psilocin inhibits CYP450 metabolism of isoforms 2A6 and 3A4

10:00 to 19:20
Digital kiosks
Andreia Machado Brito-da-Costa

e-poster

Psychological Phenotypes in Glambling Disorder: A case study using the Pathway Model

10:00 to 19:20
Digital kiosks
Ana Llorente

e-poster

Psychosocial and financial vulnerabilities in loot box purchasing: The mediating role of problem gambling

10:00 to 19:20
Digital kiosks
Anu Sirola

e-poster

Psychosocial Determinants of Cannabis Protective Behavioral Strategies: Perceived Efficacy and Social Norms

10:00 to 19:20
Digital kiosks
Fermin Fernández Calderón

e-poster

Psychosocial Factors Affecting Drug Relapse Among Youth in Pakistan

10:00 to 19:20
Digital kiosks
Abdul Waheed Tabish

e-poster

Public Health addressing illicit drug use and mental health disorders: Interinstitutional Community Intervention Group

10:00 to 19:20
Digital kiosks
Paula Pinto Oliveira

e-poster

Recreational Cannabis and Social Media Use: A Correlational Cross-Sectional Study

10:00 to 19:20
Digital kiosks
Roni Deli-Houssein

e-poster

Recreational substance use and cognition in a large cohort of young adults with hair testing: Something is not nothing

10:00 to 19:20
Digital kiosks
Lukas Eggenberger

e-poster

Reitox National Focal Point Drug Monitoring System as a Model for Monitoring Other Addictions in Czechia

10:00 to 19:20
Digital kiosks
Pavla Chomynova

e-poster

Resilience and Sense of Coherence as Mediators in the Association between Problematic Mobile Phone Use and Depression

10:00 to 19:20
Digital kiosks
Qi Dai

e-poster

Results of İntegrated Bio-Behavioral surveillance among PWID in Azerbaijan

10:00 to 19:20
Digital kiosks
Gunash Jafarova

e-poster

Rhabdomyolysis in patients following opioid overdose

10:00 to 19:20
Digital kiosks
Aleksandra Babulovska

e-poster

Riscos & Desafios Program: the students’ voice

10:00 to 19:20
Digital kiosks
Gizela Rendo

e-poster

Risk of relapse to non-opioids among patients treated with XR-NTX or BP-NLX: A randomized clinical trial

10:00 to 19:20
Digital kiosks
Arild Opheim

e-poster

Risks and challenges of scaling up the intervention – an analysis of the program dissemination process

10:00 to 19:20
Digital kiosks
Carla Rocha

e-poster

Risky online behavior in relation to social support, depression and anxiety in Czech adolescents

10:00 to 19:20
Digital kiosks
Terezie Babilonová

e-poster

Role of Psychiatric Nursing Staff in a Newly Founded Ward for Treatment of Adolescents Facing Addiction

10:00 to 19:20
Digital kiosks
Aleš Zajc

e-poster

SCHEMATIC FUNCTIONING AND EMOTIONAL REGULATION IN ALCOHOL DEPENDENCE: A CLINICAL AND NON-CLINICAL SAMPLE COMPARISON

10:00 to 19:20
Digital kiosks
Ana Catarina Nunes da Silva

e-poster

SCIRe: Substance Consumption Informative Research - testing hair in electronic music festivals

10:00 to 19:20
Digital kiosks
Ana Pego

e-poster

Scottish stakeholder views on closing the evidence to practice gap in substance use prevention

10:00 to 19:20
Digital kiosks
Tara Shivaji

e-poster

Self-inflicted cut throat injuries and substance use during COVID-19: An analysis from Nepal

10:00 to 19:20
Digital kiosks
Dipesh Bhattarai

e-poster

Self-rated health among patients in opioid agonist therapy

10:00 to 19:20
Digital kiosks
Jan Tore Daltveit

e-poster

Sleep dysregulation in alcohol use disorders. An exploratory study with a gender perspective.

10:00 to 19:20
Digital kiosks
Ana Llorente

e-poster

Smartphone addiction and sexual distress: preliminary findings of a study in Portugal

10:00 to 19:20
Digital kiosks
Pedro Campos

e-poster

Smoking among people who use drugs

10:00 to 19:20
Digital kiosks
Ingeborg Lund

e-poster

Social work diagnosis and intervention in a harm reduction service for People Who Use Drugs

10:00 to 19:20
Digital kiosks
Teresa Castro

e-poster

Spanish version of the Bergen Social Media Addiction Scale (BSMAS): validity, reliability and measurement invariance

10:00 to 19:20
Digital kiosks
Conchita Sisi Martin

e-poster

Stigma and substance use disorders: a scoping review of patient and health care professionals’ attitudes.

10:00 to 19:20
Digital kiosks
Ashlyn Schwartz

e-poster

Stigma by association among alcohol and other drug and harm reduction workers: Implications for workplace outcomes

10:00 to 19:20
Digital kiosks
Theresa Caruana

e-poster

Substance Use Among College Students in India: Necessity for Intervention

10:00 to 19:20
Digital kiosks
Anju Dhawan

e-poster

Substance Use Treatment for non-speaker of the native language: Implications for migrants and the displaced

10:00 to 19:20
Digital kiosks
Mayar Nawara

e-poster

Suicidal Behaviors and Alcohol Dependence: A Comprehensive Literature Review

10:00 to 19:20
Digital kiosks
Marco Mota Oliveira

e-poster

Systematic analysis of Interventions for Opioid Use Disorder Among Adolescents

10:00 to 19:20
Digital kiosks
Joye Anestis

e-poster

Systematic review of recovery of neuropsychological function following abstinence in people with an Alcohol Use Disorder

10:00 to 19:20
Digital kiosks
Anna Powell

e-poster

Systemic biases: Attitudes of correctional staff toward incarcerated people receiving opioid agonist treatment

10:00 to 19:20
Digital kiosks
Joëlle Maguire-L

e-poster

Tell me who you are, I'll tell you what to do: designing specific interventions for different types of gamers

10:00 to 19:20
Digital kiosks
João Faria

e-poster

The addiction nursing workforce empowerment - from international perspective to the national implementation and bac

10:00 to 19:20
Digital kiosks
Vendula Pokorná

e-poster

The association between alexithymia and binge drinking among young people

10:00 to 19:20
Digital kiosks
Pelin Alpay

e-poster

The association between psychological distress and alcohol consumption and physical activity

10:00 to 19:20
Digital kiosks
Silvia Eiken Alpers

e-poster

The Autonomic Craving Signature: a biomarker of craving for personalized addiction treatment

10:00 to 19:20
Digital kiosks
Marc Auriacombe

e-poster

The comparison and analysis of blood antioxidant levels in alcohol and drug addiction

10:00 to 19:20
Digital kiosks
Nelly Sapojnikova

e-poster

The Development of an Alcohol Strategy for the Northwest Territories, Canada

10:00 to 19:20
Digital kiosks
Bryany Denning

e-poster

The effect of Cue-induced Retrieval and Reconsolidation with Episodic Foresight on craving in opioid users receiving MMT

10:00 to 19:20
Digital kiosks
Parnian Rafei

e-poster

The effect of smoking cessation interventions on socioeconomic inequalities in smoking: A Cochrane systematic review

10:00 to 19:20
Digital kiosks
Annika Theodoulou

e-poster

The effects of syringe service programs on overdose deaths in Tennessee

10:00 to 19:20
Digital kiosks
Ryan Edgerton

e-poster

The Impact of psychotherapy on Comorbid Borderline Personality Disorder and Substance Use Disorder: A Systematic Review

10:00 to 19:20
Digital kiosks
Manuel Jesús Ruiz Muñoz

e-poster

The impact of the tobacco law on hospitalizations due to the abusive consumption of psychoactive substances

10:00 to 19:20
Digital kiosks
Filipe Pinto

e-poster

The Intersection of Gambling with Smoking and Alcohol use in Great Britain: A Cross-Sectional Survey in October 2022

10:00 to 19:20
Digital kiosks
Loren Kock

e-poster

The Last Decade in Turkish Addiction Research: A Thesis-Based Analysis

10:00 to 19:20
Digital kiosks
Belgin Varol

e-poster

The lived experience of persons receiving harm reduction services, finding an oasis in the deserted life of drug use

10:00 to 19:20
Digital kiosks
Alexandros Tifas

e-poster

The Moral Improvisation of Harm Reduction in Abstinence Based Drug Policy Amongst Frontline Drug Workers in Hong Kong

10:00 to 19:20
Digital kiosks
Katie Lowe

e-poster

The necessary adaptation of a public Therapeutic Community to new needs of the treatment process.

10:00 to 19:20
Digital kiosks
Rita Fazenda Vieira

e-poster

The potential of eHealth in the treatment of substance use disorders: a perspcitive on digital theraies

10:00 to 19:20
Digital kiosks
André Almeida

e-poster

The prevalence of cannabis use disorders in people who use medicinal cannabis: a systematic review and meta-analysis

10:00 to 19:20
Digital kiosks
Danielle Dawson

e-poster

The prevalence of Mental Health Disorders Among Cannabis Users

10:00 to 19:20
Digital kiosks
Ada Hočevar Grom

e-poster

The prevalence, risk and protective factors of the co-morbidity of neurodiversity and substance use.

10:00 to 19:20
Digital kiosks
Catherine Comiskey

e-poster

The recovery of people with addictive behaviours and dependencies: intervention strategies of social workers

10:00 to 19:20
Digital kiosks
Sara Carvalho

e-poster

The role of cartoon humor in the context of addictology efforts for the prevention of alcohol and tobacco use

10:00 to 19:20
Digital kiosks
Linda Kočvarová

e-poster

The role of coping in the association between cannabis use disorder and mental health; a one-year prospective study

10:00 to 19:20
Digital kiosks
Nora de Bode

e-poster

The role of COVID-19 in sleep quality and cognitive performance in alcohol–dependent patients

10:00 to 19:20
Digital kiosks
Lea Kozina

e-poster

The role of dissociative experiences in the link between psychological distress and Problematic Social Network Sites Use

10:00 to 19:20
Digital kiosks
Simon Ghinassi

e-poster

The role of temperamental self-regulation in predicting treatment outcome in alcohol use disorders

10:00 to 19:20
Digital kiosks
Els Santens

e-poster

THE ROLE OF WORK IN THE TREATMENT OF INDIVIDUALS RECOVERING FROM ADDICTION

10:00 to 19:20
Digital kiosks
Farshad moshiri

e-poster

The Value of Outreach (VALOR): An evaluation of the implementation of alcohol assertive outreach in Greater Manchester

10:00 to 19:20
Digital kiosks
Nikolaos Mylonas

e-poster

Therapeutic Effects of Ayahuasca: The Psychological Processes Involved in the Relief of Depression and Grief.

10:00 to 19:20
Digital kiosks
Mafalda Pinto Ribeiro

e-poster

Therapy of alcohol-dependent women serving prison sentences in Polish prisons

10:00 to 19:20
Digital kiosks
Hanna Karaszewska

e-poster

Threat or opportunity: End-user perspectives on digital interventions for treatment of cannabis use

10:00 to 19:20
Digital kiosks
Jasmin Lostedt

e-poster

Training Program for Self-management of Substance Addiction Consequences – a Randomized Controlled Trial Pilot Study

10:00 to 19:20
Digital kiosks
Paulo Seabra

e-poster

Transgender and non-binary people's experiences with alcohol reduction in the UK: A cross-sectional study

10:00 to 19:20
Digital kiosks
Dean Connolly

e-poster

TREATMENT PROGRAMS FOR CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH MENTAL AND BEHAVIORAL DISORDERS DUE TO PAS USE

10:00 to 19:20
Digital kiosks
Andrej Kastelic

e-poster

Trilhos - Evaluation of a developmental prevention program

10:00 to 19:20
Digital kiosks
Inês Abraão

e-poster

Trust in healthcare providers for information about cannabis

10:00 to 19:20
Digital kiosks
Meredith Meacham

e-poster

Twenty years of integrated treatment of dual disorders in the netherlands: lessons learned

10:00 to 19:20
Digital kiosks
Anneke van Wamel

e-poster

Understanding Overdose Risk Perception in People who use Drugs - A Systematic Review

10:00 to 19:20
Digital kiosks
Kerry B.D. Campbell

e-poster

Unmasking addictions: exploring the role of attributional styles

10:00 to 19:20
Digital kiosks
Ana Tavares

e-poster

Use of CBD and low-THC products in North Macedonia

10:00 to 19:20
Digital kiosks
Sanja Prosheva

e-poster

Using a digital client segmentation tool among clients with problematic substance use

10:00 to 19:20
Digital kiosks
Ella Plaami

e-poster

Using Functional Near Infrared Spectroscopy to Detect Neurocognitive Differences Across Social Drinking Patterns

10:00 to 19:20
Digital kiosks
Rebecca Kuiper

e-poster

Veterinary Drugs as Toxic Adulterating Substances in the Street Drug Supply

10:00 to 19:20
Digital kiosks
Barry Logan

e-poster

Voices of the unhoused from Santa Fe, New Mexico: health status, substance use, and community harm reduction views

10:00 to 19:20
Digital kiosks
Laura Brown

e-poster

When substance use disorder and eating disorder intersect: an integrated care tool.

10:00 to 19:20
Digital kiosks
Zoya Barbier

e-poster

Willingness and Contextual Considerations for Supervised Consumption Sites among People Who Inject Drugs in Stockholm

10:00 to 19:20
Digital kiosks
Elin Holmén

e-poster

Workforce development and co production as key enablers of successful service delivery.

10:00 to 19:20
Digital kiosks
Martin Blakebrough

e-poster

Working memory in context: the role of alcohol distractors in low to heavy alcohol drinkers

10:00 to 19:20
Digital kiosks
Karis Colyer-Patel

e-poster

Working Towards Health and Wellness: The Infinite Pathways of Recovery

10:00 to 19:20
Digital kiosks
Meghann Perry

e-poster

“To smoke feels gender”: A Photovoice Study of Cannabis Use Among Transgender and Non-Binary Youth

10:00 to 19:20
Digital kiosks
Christian Barborini

11:50

Oral presentation

NIDA International Program Research Update

11:50 to 13:20
Auditorium VI
Tom Clarke

Oral presentation

Understanding the research capacity of Australian alcohol and other drug services

11:50 to 13:20
Auditorium VI
Robert Stirling

Oral presentation

Report from LX24 side event - Strengthening networks and sharing innovation in practices on research and surveillance in the drugs field

11:50 to 13:20
Auditorium VI
Vickna Kasinather
Charles Parry

Oral presentation

A global perspective on the emotions associated with chemsex practice to better support the community

11:50 to 13:20
Auditorium IV
Yannick Gaudette

Oral presentation

Addressing gender, diversity, and precarity: participatory research to transform addiction services in Canada

11:50 to 13:20
Auditorium IV
Karine Bertrand

Oral presentation

Bipolar disorder and severe poisoning due to medicines or illicit substances

11:50 to 13:20
Auditorium VII
Aleksi Hamina

Oral presentation

Bringing law enforcement officers (LEO) closer to other agents of prevention: A UNODC Guiding Document

11:50 to 13:20
Room 5A
Ali Yassine

Oral presentation

Chemsex Professional Training Program in Catalonia

11:50 to 13:20
Auditorium IV
Elena Adán Ibáñez

Oral presentation

CHildren AMplified Prevention Services (CHAMPS): Amplify Children Resilience through a comprehensive prevention system

11:50 to 13:20
Room 5A
Ali Yassine

Oral presentation

Enhanced self-efficacy in HCV management: educating a multidisciplinary drug and alcohol workforce in Europe and Canada

11:50 to 13:20
Room 5C
Emma Day

Oral presentation

Exploring Australian addiction workers' views on inclusive treatment for transgender and gender diverse (TGD) clients.

11:50 to 13:20
Room 5C
Nic Robinson-Griffith

Oral presentation

Foundations of Prevention Science and Practice Curriculum: Providing Technical Assistance through Training

11:50 to 13:20
Room 5C
Maria Paula Luna Jimenez

Oral presentation

Hazardous substance use and mental health among refugees in shared accommodations – a mixed-methods study

11:50 to 13:20
Auditorium VII
Miriam Lorenz

Oral presentation

Modelling the wider socio-economic costs of problematic opioid use in the UK

11:50 to 13:20
Auditorium VIII
George Keel

Oral presentation

Prevalence of opioid dependence in Scotland, 2015-2020: results from a Multi Parameter Estimation of Prevalence model

11:50 to 13:20
Auditorium VIII
Hayley Jones

Oral presentation

Scaling up Harm Reduction: Results of the 3-year Take-Home Naloxone project NALtrain in Germany.

11:50 to 13:20
Room 5C
Simon Fleißner

Oral presentation

Substance Use, Sexual Pleasure and Recovery among gbMSM: Addressing Sexual Satisfaction in Addiction Interventions

11:50 to 13:20
Auditorium IV
Maxime Blanchette

Oral presentation

Suicide-related service presentations following residential treatment for substance use disorders: a data linkage study

11:50 to 13:20
Auditorium VII
Calvert Tisdale

Oral presentation

The gendered impacts of drug stigma - a qualitative study with 10 street-involved women who use drugs in Porto

11:50 to 13:20
Auditorium IV
Cristiana Vale Pires

Oral presentation

The impact of severe mental illness on treatment retention and all-cause mortality of people in opioid agonist treatment

11:50 to 13:20
Auditorium VII
Nicola Jones

Oral presentation

The Staying Safe Programme: A new online education approach to reducing drug related harm for university students

11:50 to 13:20
Room 5A
Adam Winstock

Oral presentation

Twenty-one years of heroin-related mortality in Australia: Joinpoint regression analysis of trends by age and gender

11:50 to 13:20
Auditorium VIII
Amanda Roxburgh

Oral presentation

Underestimate of deaths due to specific opioids in England and Wales for a decade

11:50 to 13:20
Auditorium VIII
Shuoqi Chen

Oral presentation

“Good health has nothing to do with alcohol”: perceptions and impacts of a French alcohol prevention campaign

11:50 to 13:20
Room 5A
Guillemette Quatremere

14:20

Keynote presentation

Enhancing scale-up of needle and syringe programs in the community in Sweden

14:20 to 15:50
Auditorium I
Martin Kåberg

Keynote presentation

Introduction and expansion of needle and syringe programs and opioid agonist treatment in prison in Moldova

14:20 to 15:50
Auditorium I
Svetlana Doltu

Keynote presentation

Achieving high-coverage and retention in opioid agonist treatment in the community in Spain

14:20 to 15:50
Auditorium I
Francina Fonseca

Keynote presentation

Overdose prevention site development and delivery in Switzerland

14:20 to 15:50
Auditorium I
Florian Meyer

Keynote presentation

How do we optimise and integrate the provision of harm reduction services in the community and prison?

14:20 to 15:50
Auditorium I
Julia Sheehan
Martin Kåberg
Francina Fonseca
Svetlana Doltu
Florian Meyer

Short communication

Alcohol prevention: a review using Topic Modelling

14:20 to 15:50
Room 1.08
Nina Harth

Short communication

Cannabis and mental health in Germany: a baseline estimation pre legalization

14:20 to 15:50
Room 1.08
Eva-Maria Krowartz

Oral presentation

Changes in cannabis potency and cannabis-related harms: A 22-year ecological study in Denmark

14:20 to 15:50
Room 1.07
Kristine Rømer Thomsen

Oral presentation

Drug-induced homicide laws in the US: current trends, stakeholder opinions, and public health impacts

14:20 to 15:50
Auditorium VI
Jennifer Carroll

Short communication

Evaluation of heroin-assisted treatment in Norway: Protocol for a mixed methods study

14:20 to 15:50
Room 1.08
Lars Henrik Myklebust

Oral presentation

Global coverage of interventions to prevent and manage injecting drug use related harms in prisons: a systematic review

14:20 to 15:50
Auditorium VI
Thomas Santo Jr.

Short communication

In favor or against the codependency concept: A narrative review of arguments in scientific literature

14:20 to 15:50
Room 1.08
Alexis Beaulieu-Thibodeau

Oral presentation

MATPACT: An innovative approach to finding Scotland’s forgotten generation

14:20 to 15:50
Auditorium VI
Marion Gillies

Oral presentation

Pharmacology of generic ban-evading synthetic cannabinoid receptor agonists: are new compounds spicing up the market?

14:20 to 15:50
Room 1.07
Marie Deventer

Oral presentation

Policy and Practice Responses to Drug-Related Deaths: Governance issues in English and Welsh Prisons, 2015-2021

14:20 to 15:50
Auditorium VI
Karen Duke

Short communication

Prevalence and trends of ethanol and drugs among arrested drivers in Norway in the period 2013-2023

14:20 to 15:50
Room 1.08
Ragnhild Jamt

Oral presentation

The challenge of cannabis quantification: from theory to practice

14:20 to 15:50
Room 1.07
Cláudia Sousa-Reis

Short communication

The relationship between cannabis and tobacco use - a systematic review and meta-analysis

14:20 to 15:50
Room 1.08
Tesfa Mekonen

Short communication

Tuning In for Chemistry: Setting up a multi-instrument mobile drug-checking lab at a 7-day psychedelic music festival

14:20 to 15:50
Room 1.08
Daniel Martins

16:00

Oral presentation

Increased hepatitis C and HIV incidence among people who inject drugs in Montreal, Canada, 2011-2023

16:00 to 17:30
Auditorium IV
Sarah Larney

Keynote presentation

Evidence-based prevention through collaborative action? Opportunities and challenges for community-based participatory research in prevention science

16:00 to 17:30
Auditorium I
Samuel Tomczyk

Keynote presentation

Challenges in community-based prevention

16:00 to 17:30
Auditorium I
Harry Sumnall

Keynote presentation

The key components of CTC, including forming intersectoral coalitions, using a data-driven and needs-oriented approach to select evidence-based measures, and considering local contextual conditions during implementation.

16:00 to 17:30
Auditorium I
Maximilian von Heyden

Keynote presentation

What do we (not) know about community-based prevention and how to move forward?

16:00 to 17:30
Auditorium I
Ina Koning

Oral presentation

"Boxing Clever Cork saved my life": an evaluation of an Irish early addiction recovery initiative

16:00 to 17:30
Auditorium III
Rebekah Brennan

Oral presentation

A Safer Downtown for All: Including People Who Use Drugs in the Solutions to Social Disorder

16:00 to 17:30
Auditorium III
Rob Boyd

Short communication

Accessibility, local socioeconomic disadvantage and expenditure on electronic gambling machines

16:00 to 17:30
Room 1.07
Jani Selin

Oral presentation

Acute drug-toxicity presentations involving crack cocaine to Euro-DEN Plus sentinel hospitals in Europe from 2014-2022

16:00 to 17:30
Room 5A
Isabelle Giraudon

Short communication

Associations between mental health and substance use in higher education students in Germany – a cross-sectional study

16:00 to 17:30
Room 1.08
Robert Hrynyschyn

Oral presentation

Associations of alcohol consumption with long-term mortality of ART-naïve persons seeking HIV care. 

16:00 to 17:30
Auditorium IV
Daniel Fuster

Short communication

Barriers and facilitators for accessing HCV care in PWID: a qualitative study using an intersectional approach

16:00 to 17:30
Room 1.08
Ilhame Anwar

Short communication

Barriers and facilitators to accessing drug treatment services for people who use drugs in Oman: a qualitative study.

16:00 to 17:30
Room 1.08

Oral presentation

Building Capacity For Future Evaluation of Residential Treatment for People Experiencing Homelessness and Addiction

16:00 to 17:30
Auditorium III
Ed Addison

Oral presentation

Challenges and support needs among persons with a migration background who use drugs in four metropolitan cities

16:00 to 17:30
Room 5C
Wouter Vanderplasschen

Oral presentation

Considering the prevention workforce: a study on practitioner needs when recommending substance use interventions

16:00 to 17:30
Room 1.06
Natalie Blackburn

Oral presentation

Decentralized consultation for infectious diseases with at-risk populations: preliminary results

16:00 to 17:30
Auditorium IV
Paulo Caldeira

Oral presentation

Documenting major shifts in methamphetamine and heroin prices and purity in metropolitan and rural Victoria, Australia

16:00 to 17:30
Auditorium VI
Kasun Rathnayake

Oral presentation

Drug markets and financial flows: underground banking in the Netherlands

16:00 to 17:30
Auditorium VI
Nienke Liebregts

Oral presentation

Drug poisoning deaths of under 30-year-olds – Key issues in the cause of death investigation documents

16:00 to 17:30
Room 5A
Sanna Rönkä

Oral presentation

Drug use and (non-)use of addiction treatment by women in French Guyana: gender and migration effects

16:00 to 17:30
Room 5C
Estelle Filipe

Oral presentation

Effects of recreational cannabis versus black market: A randomized controlled trial in Switzerland (WEED CARE)

16:00 to 17:30
Auditorium VI
Lavinia Baltes

Short communication

Envisioning youth-dedicated overdose prevention and drug consumption sites in Canada and Portugal

16:00 to 17:30
Room 1.08
Kali-olt Sedgemore

Oral presentation

Evaluating and comparing health quality for addiction treatment in the Lazio region, Italy

16:00 to 17:30
Room 1.06
Antonella Camposeragna

Short communication

Exploring the biopsychosocial needs of ageing heroin users in treatment in Malta: implications for service provision

16:00 to 17:30
Room 1.08
Anna Grech

Short communication

Extended hours of video game play and negative physical symptoms and pain

16:00 to 17:30
Room 1.07
Janni Leung

Short communication

Financial hardship and gambling severity: a population-based study in Finland

16:00 to 17:30
Room 1.07
Tanja Grönroos

Short communication

Harmful types of gambling: Changes and emerging trends in longitudinal helpline data

16:00 to 17:30
Room 1.07
Håkan Wall

Oral presentation

How do purity and price of cocaine affect consumption in Austria?

16:00 to 17:30
Auditorium VI
Birgit Priebe

Oral presentation

How do you make it work? A pragmatic framework for the Sustained Uptake of Service Innovations (SUSI).

16:00 to 17:30
Room 1.06
Catherine Foley

Short communication

Late relapse among ex-smokers using e-cigarettes following a quit attempt: a prospective one-year follow-up study

16:00 to 17:30
Room 1.08
Lion Shahab

Short communication

Mental health in people with hazardous cannabis and alcohol use - insights from a study of regulated cannabis sales

16:00 to 17:30
Room 1.08
Maximilian Buschner

Oral presentation

Migrants in the criminal justice system: A qualitative understanding of the role of substance use in their lives

16:00 to 17:30
Room 5C
Marjolein De Pau

Oral presentation

Mortality among first-time opioid agonist therapy patients in Austria, 2002-2021: A national retrospective cohort study

16:00 to 17:30
Room 5A
Tanja Schwarz

Oral presentation

Mothers receiving substance use treatment involved in care proceedings: A record linkage cohort study

16:00 to 17:30
Room 5A
Martha Canfield

Short communication

Online Gambling Companies’ Interpretation of Duty of Care and its Implication for Responsibilisation of Gambling Related Harm

16:00 to 17:30
Room 1.07
Maria Persson

Oral presentation

Planning and Monitoring drug and alcohol treatment in Denmark. The MapPlan project.

16:00 to 17:30
Room 1.06
Mads Uffe Pedersen

Oral presentation

Psychoactive Substance Use Among Russian Migrants Relocated to Georgia Following the 2022 Ukrainian Invasion

16:00 to 17:30
Room 5C
David Otiashvili

Oral presentation

Refugees & drug use in Belgium: A national study on drug-related intervention needs in the reception setting (DrugInt)

16:00 to 17:30
Room 5C
Charlotte de Kock

Short communication

Religiosity and gambling - moderating role of reflective thinking: A Polish-Georgian Study

16:00 to 17:30
Room 1.07
Rafał Bartczuk

Short communication

Substance induced psychosis among persons with concurrent mental health and substance use disorders under pandemic

16:00 to 17:30
Room 1.08
Jørgen G. Bramness

Short communication

Suicide by people in contact with drug and alcohol services: a national study 2021 to 2022

16:00 to 17:30
Room 1.08
Patrick Horgan

Oral presentation

Superiority and cost-effectiveness of Individual Placement and Support for people with alcohol and drug dependence

16:00 to 17:30
Auditorium III
John Marsden

Short communication

What increases the risk of problem gambling in adolescents? Findings from the Greek arm of the ESPAD study

16:00 to 17:30
Room 1.07
Alexandra Primeti

Oral presentation

“They kicked me out of hospital twice”: barriers and facilitators accessing care with an injecting-related infection

16:00 to 17:30
Auditorium IV
Samantha Colledge-Frisby

17:50

Oral presentation

20-year trends in Australian methamphetamine-related deaths: An age–period–cohort–interaction analysis

17:50 to 19:20
Auditorium IV
Oisin Stronach

Oral presentation

Achieving universal health coverage of opioid agonist treatment in Norway: a cost-utility analysis

17:50 to 19:20
Room 5B
Prayash Chaudhary

Short communication

Adão e Eva II Project – HIV, Hepatitis and other STI’s prevention and screening among hard-to-reach populations

17:50 to 19:20
Room 1.05
Paulo Anjos

Oral presentation

Adolescents spending time with their parents: does it matter to prevent risky and addictive behaviors?

17:50 to 19:20
Room 5A
Ina Koning

Oral presentation

AN IMPLEMENTATION SCIENCE EVALUATION OF SCOTLAND’S FIRST HEROIN ASSISTED TREATMENT (HAT) FACILITY

17:50 to 19:20
Room 5B
Andrew McAuley

Short communication

Are Australian pharmacists willing and prepared to offer Hepatitis C services? Findings from a representative sample

17:50 to 19:20
Room 1.05
Louisa Picco

Short communication

Being Seen and Heard: Exploring the Relational Dimension of Heroin Assisted Treatment in Norway.

17:50 to 19:20
Room 1.06
Vegard Haukland

Oral presentation

Codeine, oxycodone, and tramadol prescription prior to overdose deaths compared to toxicological findings

17:50 to 19:20
Auditorium IV
Hilde Edvardsen

Short communication

Death after residential treatment for opioid use disorder among people using fentanyl

17:50 to 19:20
Room 1.06
Jan Gryczynski

Oral presentation

Development of a mobile neuroscience-informed psychoeducation program for resilience and substance use prevention

17:50 to 19:20
Room 5A
Jasmin Vassileva

Oral presentation

Exploring social-environmental factors in recovery and reintegration of substance-related disorders: a scoping review

17:50 to 19:20
Room 5A
Mariana Vieira

Short communication

Global utilization trends for weekly/monthly injectable buprenorphine (CAM2038) in the treatment of Opioid Use Disorder

17:50 to 19:20
Room 1.06
Michael Frost

Short communication

HCV antibody and RNA testing combined with nursing and peer-based outreach to enhance HCV testing and treatment among vulnerable groups

17:50 to 19:20
Room 1.05
Solange Mendes Ascensão

Oral presentation

Heavy drinking among ‘sober generation’ youth: a longitudinal study

17:50 to 19:20
Room 5C
Marit Edland-Gryt

Short communication

Improving the model of care pathway for HCV between the drug care centres and their referral hospitals in Catalonia.

17:50 to 19:20
Room 1.05
Elena Torrell -Pedreira

Short communication

Looking under rocks: Skin infections in people who use drugs: a mixed-methods investigation in Wales

17:50 to 19:20
Room 1.05
Michelle Hughes

Oral presentation

Medical use of psychedelic substances: EUDA's monitoring of key developments

17:50 to 19:20
Auditorium VIII
Alexander Söderholm

Oral presentation

Monitoring intravenous drugs use in Spain through syringe residue analysis

17:50 to 19:20
Auditorium IV
Carlos Pernas-Fraguela

Oral presentation

Motivations for cocaine use: relation with drug use patterns, risks and how this informs prevention

17:50 to 19:20
Room 5C
Eva Blomme

Oral presentation

Motivations underlying co-use of benzodiazepines and opioids in the UK: a qualitative study

17:50 to 19:20
Room 5C
Gaby Vojt

Short communication

Oxycodone and Morphine use in hospitals and primary healthcare in Norway 2010-2021

17:50 to 19:20
Room 1.06
Eirik Haarr

Oral presentation

Parents aren’t out of the picture: Parent factors are linked with heavy episodic drinking among high school students

17:50 to 19:20
Room 5A
Lotte Vallentin-Holbech

Short communication

Prevalence and microelimination of Hepatitic C in intravenous drug users - improving linkage to care

17:50 to 19:20
Room 1.05
Eva-Carina Heier

Oral presentation

Reduced health care utilization after entering opioid agonist treatment; change in mental and somatic health domains

17:50 to 19:20
Room 5B
Thomas Clausen

Oral presentation

Route-Dependent Subjective Effects of Medical Heroin in HAT: Implications for Treatment Trajectories

17:50 to 19:20
Room 5B
Silvana De Pirro

Oral presentation

Self-therapeutic use of psilocybin, MDMA and ketamine among Dutch nightlife attendees.

17:50 to 19:20
Auditorium VIII
Frederiek Schutten

Short communication

STTBI risk reduction with OAT among people with prescription-type opioid use disorder

17:50 to 19:20
Room 1.05
M. Eugenia Socias

Oral presentation

The U.S. Psilocybin Landscape: Policy Evolution and Nationally Representative Insights

17:50 to 19:20
Auditorium VIII
Beau Kilmer

Short communication

Trends in the detection and co-detection of drugs in a population attending opioid agonist treatment: 2010 to 2020

17:50 to 19:20
Room 1.06
Gráinne Cousins

Oral presentation

What are the reasons for injecting methadone? A qualitative study among people who inject drugs in Barcelona

17:50 to 19:20
Auditorium IV
Gabriela Barbaglia

Oral presentation

‘Russian Roulette’: how do people who co-use benzodiazepines and opioids experience the absence of harm reduction?

17:50 to 19:20
Room 5C
Hannah Poulter

19:30

Discussion

Why are we not doing better at reducing drug-related deaths?

19:30 to 20:30
Auditorium I
Thomas Clausen
Marie Jauffret-Roustide
Keith Humphreys
Paul Dietze
Katri Abel-Ollo
Thu 24 Oct

11:50

Oral presentation

Long-acting injectable buprenorphine for opioid use disorder: key findings from a longitudinal qualitative study

11:50 to 13:20
Auditorium IV
Joanne Neale

e-short communication

Ensuring Quality Care: community-led monitoring of client satisfaction and accessibility of OAT programs

11:50 to 13:20
Auditorium IV
Maria Plotko

Oral presentation

Adapting Opioid Therapy: Transition from Methadone to Slow-Release Morphine Amid COVID-19 Supply Chain Disruptions

11:50 to 13:20
Auditorium IV
Artūras Barkus

Oral presentation

A Holistic Multi-Disciplinary Healthcare Pathway for Older Men who use Anabolic Androgenic Steroids

11:50 to 13:20
Room 1.08
Evelyn Hearne

Short communication

A scoping review of mass media interventions intended to reduce stigma towards people who use drugs

11:50 to 13:20
Auditorium VII
Adam Holland

Oral presentation

A wastewater-based approach to monitor shifting trends in illicit drugs consumption in Switzerland

11:50 to 13:20
Room 5A
Livia Andrani

Oral presentation

Cannabis policy and practice in Finland: from social media discussions to citizens initiatives

11:50 to 13:20
Room 1.08
Aleksi Hupli

Short communication

Changes in the use of non-prescribed hydromorphone and unregulated opioids use in Vancouver, Canada, 2018-2022

11:50 to 13:20
Auditorium VII
Kanna Hayashi

Oral presentation

Clinicians’ experience of providing heroin-assisted treatment: Key rewards and challenges

11:50 to 13:20
Room 5C
Rune Ellefsen

Short communication

Definition of public amenity in drug consumption room literature: A scoping review

11:50 to 13:20
Auditorium VII
Bianca Whiteside

Oral presentation

Drugs and climate change: knowledge gaps in monitoring environmental impacts of drugs

11:50 to 13:20
Room 1.08
Tim Surmont

Short communication

Enhancing Harm Reduction: A Qualitative Evaluation of Athens' Drug Consumption Room

11:50 to 13:20
Auditorium VII
Benjamin Scher

Oral presentation

European Hair Drug Analisys Network – A pioneer study to investigate the use of NPS and NSO

11:50 to 13:20
Room 5A
Elisa Fornero

Oral presentation

Fostering Community: A Mixed Method Analysis of Kosmicare's Mobile Drug Checking Service in Lisbon, Portugal

11:50 to 13:20
Room 5C
Helena Valente

Oral presentation

Impact of long-acting depot buprenorphine post-release from custody– Early findings from the Release Study

11:50 to 13:20
Auditorium IV
Adrian Dunlop

Oral presentation

Key challenges for alcohol epidemiology and alcohol control policy evaluation

11:50 to 13:20
Auditorium VI
Jürgen Rehm

Oral presentation

Legally grey? Drug checking perspectives in the CEECA region

11:50 to 13:20
Auditorium VI
Eliza Kurcevič

Short communication

Overdoses in the drug consumption room in Oslo: route of administration matters!

11:50 to 13:20
Auditorium VII
Desiree Eide

Oral presentation

Perceptions of family physicians in Istanbul on e-cigarettes as smoking cessation aids

11:50 to 13:20
Room 1.08
Melis Selamoglu

Oral presentation

Prevention of hazardous substance use among refugees – digital tools for the workforce in refugee aid

11:50 to 13:20
Room 5C
Jonathan Uricher

Oral presentation

Public health for whom? Unpacking the assumptions and silences in Canada's public health approach to substance use.

11:50 to 13:20
Auditorium VI
Sophie Henderson

Short communication

Reasons for (non-)using a drug consumption room: the point of view of drug users.

11:50 to 13:20
Auditorium VII
Sanda Samitca

Short communication

Safe Inhalation Pipe Provision Study: Intervening to improve policy and practice for people who use crack in England.

11:50 to 13:20
Auditorium VII
Magdalena Harris

Oral presentation

Synthesis of multisource data for the development of an advanced dashboard to monitor illicit drugs markets

11:50 to 13:20
Room 5A
Pierre Esseiva

Oral presentation

The Costs and Harms of Substance Use in Canada: Key Trends from 2007 to 2022

11:50 to 13:20
Auditorium VI
Pam Kent

Oral presentation

The situation of Harm Reduction in Spain: a qualititive approach incluying PWUD

11:50 to 13:20
Room 5C
Ester Aranda

Short communication

The Value of Peer Research: A Peer Perspective

11:50 to 13:20
Auditorium VII
Christos Anastasiou

Oral presentation

What can Portugal do to prevent be caught off guard again in the drug domain?

11:50 to 13:20
Room 5A
Alcina Correia

14:20

Oral presentation

Dynamic associations between anxiety and alcohol use from early adolescence to young adulthood.

14:20 to 15:50
Auditorium VII
Margot Peeters

Short communication

A multisite implementation trial of collaborative care for Opioid Dependence: 3-month outcomes from the EPIC-MATOD trial

14:20 to 15:50
Room 1.05
Suzanne Nielsen

Oral presentation

A randomized controlled trial of support programs for parents of treatment-refusing substance using young adults

14:20 to 15:50
Auditorium VII
Ola Siljeholm

Short communication

A socio-ecological systematic review of harm reduction interventions addressing the U.S. opioid overdose epidemic

14:20 to 15:50
Room 1.05
Katie McCormick

Short communication

An economic evaluation of Catalonia’s Needle Exchange Programme (NEP). Cost-Benefit analysis

14:20 to 15:50
Room 1.05
Asier Narbarte Arzuaga

Oral presentation

Associations between opioid agonist therapy exposure and chronic pain characteristics among people who inject drugs

14:20 to 15:50
Auditorium IV
Sasha Udhesister

Oral presentation

Community-wide effects of building a resilient community healthcare workforce

14:20 to 15:50
Room 5C
Carol Jones

Oral presentation

Conceptualising the right to health in the context of the world drug problem

14:20 to 15:50
Auditorium VI
Alison Ritter

Oral presentation

Drug-related deaths among housed and homeless individuals in the UK and the USA

14:20 to 15:50
Auditorium IV
Emmert Roberts

Oral presentation

Drug-related mortality associated with gabapentinoid/Z-drug co-prescribing among opioid-agonist treatment recipients

14:20 to 15:50
Auditorium IV
Megan Glancy

Short communication

Effect of integrated smoking cessation treatment on smoking intensity among persons who receive opioid agonist treatment

14:20 to 15:50
Room 1.05
Karl Trygve Druckrey-Fiskaaen

Oral presentation

EXPERIENCES OF DRUG CONSUMPTION ROOM PROFESSIONALS

14:20 to 15:50
Room 5C
Patricia Domingos Belo

Oral presentation

Female-specific trends and treatment needs for substance use disorder among homeless and at-risk females

14:20 to 15:50
Room 1.08
Anne Marie Carew

Oral presentation

Gender and drugs: Experiences of stigma/toxicophobia and narcofeminist narratives

14:20 to 15:50
Room 1.08
Marie Jauffret-Roustide

Oral presentation

High body mass index is prevalent in people with opioid use disorder in Northern England and increases risk of death

14:20 to 15:50
Auditorium IV
Caroline Copeland

Short communication

Homeless people and mental health: an observational study in an Emergency Shelter in Lisbon

14:20 to 15:50
Room 1.05
Gonçalo Henriques

Oral presentation

Innovation in caring for individuals experiencing polydrug use disorder: opportunities to understand multi-morbidities

14:20 to 15:50
Room 5C
Alexander Baldacchino

Oral presentation

International drug policy constellations: exploring the role of power and morality in international drug policy debates

14:20 to 15:50
Auditorium VI
Alex Stevens

Short communication

Multi Parameter Estimation of Prevalence modelling: methods to estimate the prevalence of opioid dependence in Scotland

14:20 to 15:50
Room 1.05
Andreas Markoulidakis

Oral presentation

Policy Responses to Drug-Related Deaths: The power of numbers?

14:20 to 15:50
Auditorium IV
Lena Eriksson

Oral presentation

Policy responses to drug-related deaths: Using a Social Determinants of Health framework analysis to inform policy

14:20 to 15:50
Auditorium VI
Aileen O'Gorman

Oral presentation

Squandered sexenio: applying drug policy constellations to the failure of marijuana legalization in Mexico (2018-2024)

14:20 to 15:50
Auditorium VI
Jonas von Hoffmann

Oral presentation

Substance use variation among LGBTQ+ youth: stress, resilience and ecosystemic intervention

14:20 to 15:50
Auditorium VII
Julie-Christine Cotton

Short communication

Treatment pathways and transitions of young adults during opioid maintenance treatment

14:20 to 15:50
Room 1.05
Sanna Iivonen

Oral presentation

Understanding substance use and affective symptoms in late adolescents in an urban context: A network approach

14:20 to 15:50
Auditorium VII
Helle Larsen

Oral presentation

Unveiling the Nexus of Addiction, Violence, and Risk: Generational Patterns in Female Populations

14:20 to 15:50
Room 1.08
Sabrina Molinaro

Oral presentation

Vulnerabilities and agencies of women who use and sell drugs in Bordeaux and Montréal

14:20 to 15:50
Room 1.08
Sarah Perrin

Oral presentation

What do clinicians think about psychedelic assisted therapy? An Australian perspective.

14:20 to 15:50
Room 5C
Zachary Bryant

16:00

Oral presentation

A national program to scale-up decentralized HCV point-of-care testing and treatment in Australia

16:00 to 17:30
Auditorium IV
Jason Grebely

Short communication

Chronic alcohol exposure and thiamine transport in BBB in Alcohol Use Disorder

16:00 to 17:30
Room 1.06
Joana Teixeira

Short communication

Epigenetic modulation of in vitro neurodifferentiation of NG108-15 cells by the synthetic cannabinoid THJ-2201

16:00 to 17:30
Room 1.06
Catarina Pereira-Teixeira

Short communication

Exploring the bioavailability and hepatotoxic effects of psychoactive chloro-cathinones.

16:00 to 17:30
Room 1.06
Rita Pacheco

Oral presentation

HCV Community-led monitoring: from consultation to effective policy contributions

16:00 to 17:30
Auditorium IV
Lynn Jefferys
Joana Canedo

Short communication

Human-relevant concentrations of synthetic cannabinoid THJ-2201 alter mitochondrial dynamics during neurodifferentiation

16:00 to 17:30
Room 1.06
Rui Filipe Malheiro

Short communication

Introducing the Theory of Preloading: A Cognitive-Behavioural Motivational Model

16:00 to 17:30
Room 1.06
Jacob Sorbello

Oral presentation

Modelling the impact of scaling up of HCV case finding and treatment for people who inject drugs in England

16:00 to 17:30
Auditorium IV
Zoe Ward

Oral presentation

Pilot HCV Birth Cohort Screening in UK Primary Care using a postal oral fluid home testing kit: the HEPCAPP StudyPP STUDY

16:00 to 17:30
Auditorium IV
Matt Hickman

Short communication

Synthetic cannabinoids ADB-FUBINACA and THJ-2201 dysregulate osteogenesis-related mechanisms in vitro

16:00 to 17:30
Room 1.06
João Pedro Silva

Short communication

Unraveling the genetic architecture of smoking: pathways of genetic risk through addiction and socioeconomics

16:00 to 17:30
Room 1.06
Adrià Túnez

17:50

Oral presentation

Cocaine use on the rise – are politicians and city level services prepared for the emerging trend of crack cocaine?

17:50 to 19:20
Auditorium III
Else Kristin Utne Berg

Oral presentation

Dual diagnosis and their care pathways for help-seeking: a multi-center study from India

17:50 to 19:20
Auditorium VII
Abhishek Ghosh

Oral presentation

Impact of mental health on retention in OAT

17:50 to 19:20
Auditorium VII
Lucy Thi Tran

Oral presentation

Intervention development of a nature-based programme for co-occurring mental health and substance use problems.

17:50 to 19:20
Auditorium VII
Wendy Masterton

Oral presentation

Islands in the stream: The accessibility of mental health care for persons with substance use problems in Belgium

17:50 to 19:20
Auditorium VII
Clara De Ruysscher

Oral presentation

It is time to take nitrous oxide seriously

17:50 to 19:20
Room 5C
Julaine Allan

Oral presentation

Misuse of psychoactive medicines and its harmful consequences in Portugal

17:50 to 19:20
Auditorium VIII
Ana Araújo

Oral presentation

Nangs in Australia: Investigating nitrous oxide use among people who regularly use MDMA and/or other illicit stimulants

17:50 to 19:20
Room 5C
Jodie Grigg

Oral presentation

New challenges for outpatient care: trends from twenty years of monitoring treatment demand in the city of Hamburg

17:50 to 19:20
Room 5C
Marcus Martens

Oral presentation

Population aging and apparent decline in initiation of injecting drug use in Australia

17:50 to 19:20
Room 5C
Olivia Price

Oral presentation

Responding to the identification of nitazenes within the illicit diazepam market

17:50 to 19:20
Auditorium III
Josie Smith

Oral presentation

Socioeconomic risk factors for long-term prescription opioid use: A national registry-linkage study

17:50 to 19:20
Auditorium VIII
Ingvild Odsbu

Oral presentation

Understanding Drug Use in a Dutch Prison: A Call for Improved Research and Care and Lessons learned

17:50 to 19:20
Auditorium III
Daan van der Gouwe

Oral presentation

Using intensive longitudinal data to investigate predictors of cannabis and opioid use among patients with chronic pain

17:50 to 19:20
Auditorium VIII
Johannes Thrul

Oral presentation

Words vs. strands: Does the concordance of self-reported and hair-analyzed substance use of young adults change over time?

17:50 to 19:20
Auditorium III
Clarissa Janousch
Fri 25 Oct

11:50

Short communication

#What´sUP_TuDecides – Healthy Influencer of Internet and Gaming Use

11:50 to 13:20
Room 1.06
Carla Andrade

Oral presentation

Accidental versus intentional drug overdose deaths: a national register linkage study

11:50 to 13:20
Auditorium IV
Rebecca McDonald

Oral presentation

Advancing Harm Reduction and Saving Lives: A Comprehensive Evaluation of Initiatives and Outcomes in Greece.

11:50 to 13:20
Room 5A
Athanasios Theocharis

Short communication

An action plan for synthetic opioids - The Zurich approach

11:50 to 13:20
Room 1.05
Dominique Schori

Oral presentation

An online survey of cannabis users and ex-users in Ireland

11:50 to 13:20
Room 5B
Philip James

Oral presentation

Behind the frontlines: Exploring mental well-being and burnout among harm reduction workers

11:50 to 13:20
Room 1.07
Katie McCormick

Short communication

Community attitudes towards sanction and health-based interventions for individuals caught drug-driving in Australia

11:50 to 13:20
Room 1.05
Sara Liu

Oral presentation

Current perspectives on the research and medical use of psychedelic drugs for alcohol addiction treatment

11:50 to 13:20
Auditorium VI
Anton Gomez-Escolar

Short communication

Development of an evidence-based classification framework for psychoactive substances in the illicit drug market

11:50 to 13:20
Room 1.05
Michèle Boileau-Falardeau

Oral presentation

Do Self-Report Drug Use Surveys Produce the Same Results in Print and Online Mode? Findings from a Dual Mode Survey.

11:50 to 13:20
Room 5B
Stelios Stylianou

Oral presentation

Drug checking: a harm reduction intervention to address the illicit drug toxicity crisis in a Canadian setting

11:50 to 13:20
Room 5A
Lianping Ti

Oral presentation

Drug-induced deaths and non-fatal poisonings in youth – associations with ACE and psychiatric morbidity

11:50 to 13:20
Auditorium IV
Karoliina Karjalainen

Short communication

Exploring characteristics of videogame use and mental health in expert and casual female gamers

11:50 to 13:20
Room 1.06
Roxanne Hébert-Ratté

Short communication

Gabapentinoids in Ireland (2010-2020): trends in prescribing, law enforcement drug seizures & post-mortem toxicology

11:50 to 13:20
Room 1.05
Gráinne Cousins

Short communication

Increasing availability and production of synthetic cathinones in Europe – a perspective from the EU EWS

11:50 to 13:20
Room 1.05
Gregorio Planchuelo

Short communication

MDMA misinformation: what dealers claim versus the actual MDMA content in ecstasy pills in the netherlands

11:50 to 13:20
Room 1.05
Lavinia Stegemann

Short communication

Media portrayal of sports betting in Canada before and after Bill C-218

11:50 to 13:20
Room 1.06
Luke Clark

Oral presentation

Needs & Modalities of Drug checking for Drug Users: Perspective of People with Lived Experience and Service Providers.

11:50 to 13:20
Room 5A
Jean-Sébastien Fallu

Short communication

New research unit provides evidence to address national addictions policy challenges

11:50 to 13:20
Room 1.05
Leonie Brose

Oral presentation

Online approach and characteristics of the hidden population with substance use disorder that doesn’t reach treatment

11:50 to 13:20
Room 5B
Ilias Paraskevopoulos

Oral presentation

Overdoses in Healthcare Workers: A thematic framework analysis of coroner reports

11:50 to 13:20
Room 1.07
Thikra Algahtani

Oral presentation

Prevalence of Benzodiazepine Prescription Prior to Overdose Deaths Compared to Toxicological Findings

11:50 to 13:20
Auditorium IV
Anna Armika Tussilago Nyman

Oral presentation

Psychedelic therapy in the treatment of addiction: the past, present and future

11:50 to 13:20
Auditorium VI
Rayyan Zafar

Short communication

Sex differences in gaming disorder: Implication for a comprehensive treatment in lower-middle income country

11:50 to 13:20
Room 1.06
Kristiana Siste

Oral presentation

Suicide in people prescribed opioid-agonist therapy (OAT) in Scotland, 2011-2020: a national retrospective cohort study.

11:50 to 13:20
Auditorium IV
Rosalyn Fraser

Short communication

The comparison of gaming and gambling in relation to decision-making behavior and implicit associations

11:50 to 13:20
Room 1.06
Nanne Dominick

Short communication

The emergence of nitazenes on the Irish heroin market: Lessons learned and challenges moving forward

11:50 to 13:20
Room 1.05
Nicki Killeen

Short communication

The Football Fans and Betting Project – Findings from an early intervention for male sports bettors

11:50 to 13:20
Room 1.06
Blair Biggar

Oral presentation

The Mental Health Challenges Faced by Harm Reduction Staff

11:50 to 13:20
Room 1.07
Laoise Darragh

Oral presentation

The old kid in the block: Unpacking signals of increased availability and use of ketamine

11:50 to 13:20
Auditorium VI
Rita Jorge

Oral presentation

The Pharmacological Management of Ketamine Use Disorder: A Systematic Review

11:50 to 13:20
Auditorium VI
Emmert Roberts

Oral presentation

Vicarious Trauma Among Nurses Working in Addiction Services and the Role of Leadership: A European Mixed Methods Study

11:50 to 13:20
Room 1.07
K. Nicki Annunziata

Short communication

Video gaming in older adults: Resilience to impairment

11:50 to 13:20
Room 1.06
Daniel Stjepanovic

Short communication

Video gaming: observational, genetic, and causal associations with cognition and health

11:50 to 13:20
Room 1.06
Joelle Pasman

Oral presentation

What can we learn about poly-drug use among frequent cannabis users? results from the European Web Survey on Drugs

11:50 to 13:20
Room 5B
Davide Fortin

Oral presentation

What you might do versus what you actually do: measuring participant drug behaviours in drug checking services

11:50 to 13:20
Room 5A
Anna Olsen

14:20

Short communication

Addressing the needs of individuals with concurrent disorders: a complexity arising

14:20 to 15:50
Room 1.05
karine Gaudreault

Oral presentation

Are Take-Home Naloxone kits available at witnessed overdose events - a European Naloxone Outcome Research Study

14:20 to 15:50
Auditorium IV
Teodora Dascal

Short communication

Breaking Chains: Interventions for Reducing Internalized Stigma and Boosting Self-Esteem in Substance Use Behaviors

14:20 to 15:50
Room 1.05
Andreia Florido

Oral presentation

Development, implementation and liquidation of a national Danish Train-the-Trainer system 2010 - 2023

14:20 to 15:50
Auditorium IV
Henrik Thiesen

Oral presentation

Does Variation in Local Policy Mediate the Impact of Legal Cannabis Markets on Adolescent Cannabis Use?

14:20 to 15:50
Auditorium III
Rosalie Liccardo Pacula

Oral presentation

Drug an ALcohol Related Intoxication Among Young Adolecents in Palestine

14:20 to 15:50
Auditorium III
Saed Bilbaisi

Oral presentation

Evaluating a pilot intervention development programme utilising respiratory monitoring to prevent drug-related deaths

14:20 to 15:50
Auditorium IV
Kristina Hnízdilová

Short communication

Functional recovery among patients with dual disorders: the role of stigma

14:20 to 15:50
Room 1.05
Nusa Segrec

Short communication

Intervention variability predicts social rehabilitation indicators at discharge in long-term residential treatment.

14:20 to 15:50
Room 1.05
Katia Barreto

Short communication

Mitigating Trauma and Problematic Drug Use with a Focus on Empathy – Insights from Metzineres

14:20 to 15:50
Room 1.05
Aura Roig Forteza

Oral presentation

New processes of normalisation? Understanding changes in young people's drug use in the UK.

14:20 to 15:50
Auditorium III
Harry Sumnall

Oral presentation

The (cost-)effectiveness of contingency management for cannabis use disorder in youth: A randomized controlled trial

14:20 to 15:50
Auditorium III
Eva Garssen

Short communication

Towards a better connection

14:20 to 15:50
Room 1.05
Chico Taguba

Short communication

Trauma-Informed care approach with people who use drugs

14:20 to 15:50
Room 1.05
Joana Pires

Oral presentation

Who reports witnessing an opioid overdose? : Findings from the European naloxone outcome research study (NalPORS)

14:20 to 15:50
Auditorium IV
Clare Mackie